Exploring the Potential of Hesperidin in Preventing Hypertrophic Scars: Insights from a Rabbit Ear Model

References

• Zhang T, Wang X-F, Wang Z-C, et al. Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation. Biomed Pharmacother. 2020;129:110287. doi:10.1016/j.biopha.2020.110287
   PubMed Web of Science ®Google Scholar
• Ud-Din S, Bayat A. New insights on keloids, hypertrophic scars, and striae. Dermatol Clin. 2014;32(2):193–209. doi:10.1016/j.det.2013.11.002
   PubMed Web of Science ®Google Scholar
• Zhu H, Tamot B, Quinton M, Walton J, Hacker RR, Li J. Influence of tissue origins and external microenvironment on porcine foetal fibroblast growth, proliferative life span and genome stability. Cell Prolif. 2004;37(3):255–266. doi:10.1111/j.1365-2184.2004.00310.x
   PubMed Web of Science ®Google Scholar
• Valls RM, Pedret A, Calderón-Pérez L, et al. Effects of hesperidin in orange juice on blood and pulse pressures in mildly hypertensive individuals: a randomized controlled trial (Citrus study). Eur J Nutr. 2021;60(3):1277–1288. doi:10.1007/s00394-020-02279-0
   PubMed Web of Science ®Google Scholar
• Ortiz AD, Fideles SO, Reis CH, et al. Therapeutic effects of citrus flavonoids neohesperidin, hesperidin and its aglycone, hesperetin on bone health. Biomolecules. 2022;12(5):626. doi:10.3390/biom12050626
   PubMed Web of Science ®Google Scholar
• Aggarwal V, Tuli HS, Thakral F, et al. Molecular mechanisms of action of hesperidin in cancer: recent trends and advancements. Exp Biol Med. 2020;245(5):486–497. doi:10.1177/1535370220903671
   PubMed Web of Science ®Google Scholar
• Man M-Q, Yang B, Elias PM. Benefits of hesperidin for cutaneous functions. Evid Based Complement Alternat Med. 2019;2019:2676307. doi:10.1155/2019/2676307
   PubMed Web of Science ®Google Scholar
• Menchaca AD, Style CC, Olutoye OO. A review of hypertrophic scar and keloid treatment and prevention in the pediatric population: where are we now? Adv Wound Care. 2022;11(5):255–279. doi:10.1089/wound.2021.0028
   Web of Science ®Google Scholar
• Chen D, Li Q, Zhang H, et al. Traditional Chinese medicine for hypertrophic scars-A review of the therapeutic methods and potential effects. Front Pharmacol. 2022;13:1025602. doi:10.3389/fphar.2022.1025602
   PubMedGoogle Scholar
• Lichtman MK, Otero-Vinas M, Falanga V. Transforming growth factor beta (TGF-β) isoforms in wound healing and fibrosis. Wound Repair Regen off Publ Wound Heal Soc and Eur Tissue Repair Soc. 2016;24(2):215–222.
   PubMed Web of Science ®Google Scholar
• Wu C, Jiang J, Boye A, Jiang Y, Yang Y. Compound Astragalus and Salvia miltiorrhiza extract suppresses rabbits’ hypertrophic scar by modulating the TGF-β/Smad signal. Dermatology. 2014;229(4):363–368. doi:10.1159/000365784
   PubMed Web of Science ®Google Scholar
• Zhai X, Ding J, Tang Z. Resveratrol inhibits proliferation and induces apoptosis of pathological scar fibroblasts through the mechanism involving TGF-β1/smads signaling pathway. Cell Biochem Biophys. 2015;71(3):1267–1272. doi:10.1007/s12013-014-0317-6
   PubMed Web of Science ®Google Scholar
• Choi EJ. Hesperetin induced G1-phase cell cycle arrest in human breast cancer MCF-7 cells: involvement of CDK4 and p21. Nutr Cancer. 2007;59(1):115–119. doi:10.1080/01635580701419030
   PubMed Web of Science ®Google Scholar
• Nalini N, Aranganathan S, Kabalimurthy J. Chemopreventive efficacy of hesperetin (citrus flavonone) against 1,2-dimethylhydrazine-induced rat colon carcinogenesis. Toxicol Mech Methods. 2012;22(5):397–408. doi:10.3109/15376516.2012.673092
   PubMed Web of Science ®Google Scholar
• Patil JR, Chidambara Murthy KN, Jayaprakasha GK, Chetti MB, Patil BS. bioactive compounds from Mexican lime (Citrus aurantifolia) juice induce apoptosis in human pancreatic cells. J Agric Food Chem. 2009;57(22):10933–10942. doi:10.1021/jf901718u
   PubMed Web of Science ®Google Scholar
• Sivagami G, Vinothkumar R, Bernini R, et al. Role of hesperetin (a natural flavonoid) and its analogue on apoptosis in HT-29 human colon adenocarcinoma cell line--A comparative study. Food Chem Toxicol an Int J Publ Br Ind Biol Res Assoc. 2012;50(3–4):660–671. doi:10.1016/j.fct.2011.11.038
   PubMed Web of Science ®Google Scholar
• Zarebczan B, Pinchot SN, Kunnimalaiyaan M, Chen H. Hesperetin, a potential therapy for carcinoid cancer. Am J Surg. 2011;201(3):329–32; discussion 333. doi:10.1016/j.amjsurg.2010.08.018
   PubMed Web of Science ®Google Scholar
• Choi EJ, Kim GD, Chee K-M, Kim G-H. Effects of hesperetin on vessel structure formation in mouse embryonic stem (mES) cells. Nutrition. 2006;22(9):947–951. doi:10.1016/j.nut.2006.05.004
   PubMed Web of Science ®Google Scholar
• Zhou Z, Kandhare AD, Kandhare AA, Bodhankar SL. Hesperidin ameliorates bleomycin-induced experimental pulmonary fibrosis via inhibition of TGF-beta1/Smad3/AMPK and IkappaBalpha/NF-kappaB pathways. EXCLI J. 2019;18:723–745. doi:10.17179/excli2019-1094
   PubMed Web of Science ®Google Scholar
• Mahmoud AM, Mohammed HM, Khadrawy SM, Galaly SR. Hesperidin protects against chemically induced hepatocarcinogenesis via modulation of Nrf2/ARE/HO-1, PPARγ and TGF-β1/Smad3 signaling, and amelioration of oxidative stress and inflammation. Chem Biol Interact. 2017;277:146–158. doi:10.1016/j.cbi.2017.09.015
   PubMed Web of Science ®Google Scholar
• Wu F, Jiang L, He X, Zhu P, Li J. Effect of hesperidin on TGF-beta1/Smad signaling pathway in HSC. China J Chinese Mater Medica. 2015;40(13):2639–2643.
   Google Scholar
• Nasehi Z, Kheiripour N, Taheri MA, Ardjmand A, Jozi F, Shahaboddin ME. Efficiency of hesperidin against liver fibrosis induced by bile duct ligation in rats. Biomed Res Int. 2023;2023:5444301. doi:10.1155/2023/5444301
   PubMed Web of Science ®Google Scholar
• Kim H-J, Jin B-R, H-J A. Hesperidin ameliorates benign prostatic hyperplasia by attenuating cell proliferation, inflammatory response, and epithelial-mesenchymal transition via the TGF-β1/Smad signaling pathway. Biomed Pharmacother. 2023;160:114389. doi:10.1016/j.biopha.2023.114389
   PubMed Web of Science ®Google Scholar
• Yang Y, Wolfram J, Shen H, Fang X, Ferrari M. Hesperetin: an inhibitor of the transforming growth factor-β (TGF-β) signaling pathway. Eur J Med Chem. 2012;58:390–395. doi:10.1016/j.ejmech.2012.10.028
   PubMed Web of Science ®Google Scholar